Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-Reported Outcomes Associated With COVID-19 and Influenza: A Prospective Survey Study on Outpatient Symptomatic Adults With Test-Confirmed Illness in the United States

NCT05160636 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05160636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05160636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-Reported Outcomes Associated With COVID-19 and Influenza: A Prospective Survey Study on Outpatient Symptomatic Adults With Test-Confirmed Illness in the United States
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
January 31, 2022
Completion date
January 31, 2027
Enrollment
999 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019, covid-19, influenza